Next report date
Report period
Q1 2024
EPS estimate
−0.45USD
Revenue estimate
—
−1.11USD
−2.20 MUSD
1.79 M
About XORTX Therapeutics Inc.
Sector
CEO
Allen Warren Davidoff
Headquarters
Calgary
Website
Employees (FY)
17
Founded
2011
FIGI
BBG00KVK0YG4
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XRTX is 2.80 USD — it has decreased by 3.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange XORTX Therapeutics Inc. stocks are traded under the ticker XRTX.
XORTX Therapeutics Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
XRTX stock is 4.01% volatile and has beta coefficient of 2.18. Check out the list of the most volatile stocks — is XORTX Therapeutics Inc. there?
XRTX earnings for the last quarter are −0.67 USD per share, whereas the estimation was −2.02 USD resulting in a 66.62% surprise. The estimated earnings for the next quarter are −0.69 USD per share. See more details about XORTX Therapeutics Inc. earnings.
Yes, you can track XORTX Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
XRTX stock has fallen by 11.40% compared to the previous week, the month change is a 27.28% fall, over the last year XORTX Therapeutics Inc. has showed a 52.15% decrease.
XRTX net income for the last quarter is 2.77 M USD, while the quarter before that showed −1.32 M USD of net income which accounts for 310.71% change. Track more XORTX Therapeutics Inc. financial stats to get the full picture.
Today XORTX Therapeutics Inc. has the market capitalization of 5.76 M, it has decreased by 3.55% over the last week.
No, XRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, XRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XORTX Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 17.00 employees. See our rating of the largest employees — is XORTX Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XORTX Therapeutics Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XORTX Therapeutics Inc. stock shows the strong sell signal. See more of XORTX Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on XORTX Therapeutics Inc. future price: according to them, XRTX price has a max estimate of 13.99 USD and a min estimate of 10.24 USD. Read a more detailed XORTX Therapeutics Inc. forecast: see what analysts think of XORTX Therapeutics Inc. and suggest that you do with its stocks.